Top holdings
27.48%Per cent of portfolio in top holdings
| Holding | % of portfolio |
|---|---|
| UroGen Pharma Ltd | 4.04% |
| Trevi Therapeutics Inc | 3.27% |
| EyePoint Pharmaceuticals Inc | 3.14% |
| argenx SE | 3.11% |
| Cogent Biosciences Inc | 2.85% |
| Ascendis Pharma AS ADR | 2.81% |
| ORIC Pharmaceuticals Inc | 2.78% |
| Janux Therapeutics Inc Ordinary Shares | 2.75% |
| Krystal Biotech Inc | 2.73% |
As of Nov 30 2025. Top holdings excludes cash and cash equivalents.
Sector weighting
| Sector | % of portfolio |
|---|---|
| Healthcare | 103.25% |
As of Feb 28 2026.
Regional holdings
| Holding | % of portfolio |
|---|---|
| USA | 94.08% |
| China | 3.93% |
| Canada | 3.41% |
| Denmark | 2.03% |
| Netherlands | 1.99% |
| UK | 1.82% |
| France | 1.50% |
As of Feb 28 2026.
